Targeting low-oxygen patches inside lung cancer tumors could help prevent drug resistance
Friday, August 26, 2016 - 05:01
in Health & Medicine
With the right treatment schedule, medications known as hypoxia-activated prodrugs (HAPs) could help prevent drug resistance in a subtype of lung cancer, according to a study.